CLC bio and Abcam today announced that CLC bio has met the first important milestone of the two companies’ collaboration: the development of a customized epitope prediction software solution to augment Abcam’s high through-put monoclonal antibody development program. Through automation of labor intensive manual workflows and by applying expert scientific knowledge, CLC bio’s customized bioinformatics […]
Abcam has appointed Jeffrey Iliffe, a highly experienced finance professional with a track record in the City, the healthcare industry and in e-commerce as its new Chief Financial Officer. Mr Iliffe, who has been working as a financial consultant at Abcam for the past 4 months, will join the Company’s Board on 20 November 2007. […]
Abcam is now offering same day delivery for scientists ordering from Cambridge in the UK! Orders must be placed by 12 noon (UK time) To all addresses in Cambridge UK No extra cost to you! We are working with local courier firm Outspoken Delivery to ensure that your antibodies and reagents get to you even […]
And still growing! Abcam is working hard to provide everything your research needs The Abcam team is working hard, adding new products every day and adding new information to the datasheets of existing products. In March 2007 we reached the landmark of having over 30,000 products in our catalog. For our customers this means: More […]
Abcam is pleased to announce its participation in the EPIgenetic TReatment Of Neoplastic disease (EPITRON) project, as a partner and collaborator. EPITRON is funded by the European Union under the 6th Framework Programme. This multi-disciplinary consortium will define ‘epigenetic’ alterations between cancer and healthy cells and work to develop an entire pipeline of novel therapeutic […]
Create an Abcam account in January and we’ll donate $2 to MSF For every new scientist that registers on our website in January we will give $2 to Médecins Sans Frontières (MSF). ** Register now! ** Simply fill in the short online form with your details. It should only take only 1-2 minutes. This will create […]
Up to 300 Abpoints now available for each Abreview! In an effort to increase the number of customer reviews (Abreviews) for antibodies with little or no customer feedback, extra Abpoints are now available for reviewing these antibodies. Scientists can earn between 50 and 300 Abpoints for each Abreview. The number of Abpoints awarded now depends […]
Abcam has appointed two additional Non-Executive Directors to its board: Timothy George Dye and Mark John Alexander Webster. Tim Dye, age 43, is currently Chairman and Chief Executive of William Ransom & Son plc, an AIM quoted healthcare company, as well as being a director of Noble Troy Ltd. Over the past six years, and […]
The European Mediscience awards dinner, held annually in June, recognises and rewards excellence within the quoted life-sciences sector, while also providing a forum for the mediscience industry and the City to meet in a relaxed and convivial atmosphere. The event was sponsored by Evolution Securities, in association with the London Stock Exchange and the BioIndustry […]
Our new automated storage and retrieval system has many benefits for you… We have recently implemented a new storage and retrieval system to enable us to further improve the excellent reliability of our antibodies which is the core of our Abpromise. It will also enable us to despatch products faster with greater accuracy, thus enabling […]
Registered Office:
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
© Abcam Limited. all rights reserved.
Abcam Limited is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds.
Website by FisherPaul